{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:32:49Z","timestamp":1789169569859,"version":"build-2803163510"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.canlet.2020.02.017","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T23:43:58Z","timestamp":1581723838000},"page":"152-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Fallopian tube initiation of high grade serous ovarian cancer and ovarian metastasis: Mechanisms and therapeutic implications"],"prefix":"10.1016","volume":"476","author":[{"given":"Tova M.","family":"Bergsten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna E.","family":"Burdette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2020.02.017_bib1","first-page":"7","article-title":"Cancer statistics","volume":"68","author":"Siegel","year":"2018","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.canlet.2020.02.017_bib2","series-title":"SEER Cancer Statistics Review","year":"2019"},{"key":"10.1016\/j.canlet.2020.02.017_bib3","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.canlet.2020.02.017_bib4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","article-title":"The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded","volume":"186","author":"Kurman","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2020.02.017_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrc.2016.113","article-title":"The disparate origins of ovarian cancers: pathogenesis and prevention strategies","volume":"17","author":"Karnezis","year":"2017","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.canlet.2020.02.017_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.canlet.2020.02.017_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1158\/0008-5472.CAN-15-1382","article-title":"It's totally Tubular....Riding the new wave of ovarian cancer research","volume":"76","author":"Perets","year":"2016","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.02.017_bib8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2020.02.017_bib9","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s41467-017-01217-9","article-title":"Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma","volume":"8","author":"Ducie","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2020.02.017_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju410","article-title":"Ovarian cancer risk after salpingectomy: a nationwide population-based study","volume":"107","author":"Falconer","year":"2015","journal-title":"J. Natl. Canc. Inst."},{"key":"10.1016\/j.canlet.2020.02.017_bib11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/aogs.12516","article-title":"Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study","volume":"94","author":"Madsen","year":"2015","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.canlet.2020.02.017_bib12","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1158\/1078-0432.CCR-04-2509","article-title":"Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon","volume":"11","author":"Marquez","year":"2005","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2020.02.017_bib13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/path.2739","article-title":"Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube","volume":"222","author":"Chen","year":"2010","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2020.02.017_bib14","doi-asserted-by":"crossref","first-page":"6090","DOI":"10.3390\/ijms14036090","article-title":"PAX2 expression in ovarian cancer","volume":"14","author":"Song","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2020.02.017_bib15","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/modpathol.2010.119","article-title":"High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression","volume":"23","author":"Roh","year":"2010","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.canlet.2020.02.017_bib16","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1158\/1940-6207.CAPR-15-0121-T","article-title":"Divergent roles of PAX2 in the etiology and progression of ovarian cancer","volume":"8","author":"Al-Hujaily","year":"2015","journal-title":"Canc. Prev. Res."},{"key":"10.1016\/j.canlet.2020.02.017_bib17","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/modpathol.2011.175","article-title":"PAX2-null secretory cell outgrowths in the oviduct and their relationship to pelvic serous cancer","volume":"25","author":"Quick","year":"2012","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.canlet.2020.02.017_bib18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/PGP.0000000000000207","article-title":"Molecular alterations of TP53 are a defining feature of ovarian high-grade serous carcinoma: a rereview of cases lacking TP53 mutations in the cancer genome Atlas ovarian study","volume":"35","author":"Vang","year":"2016","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.canlet.2020.02.017_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/pgp.0b013e31814b191f","article-title":"Serous carcinogenesis in the fallopian tube: a descriptive classification","volume":"27","author":"Jarboe","year":"2008","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.canlet.2020.02.017_bib20","first-page":"848","article-title":"Advances in serous tubal intraepithelial carcinoma: correlation with high grade serous carcinoma and ovarian carcinogenesis","volume":"7","author":"Li","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.canlet.2020.02.017_bib21","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2020.02.017_bib22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1477-7827-12-60","article-title":"The hormonal composition of follicular fluid and its implications for ovarian cancer pathogenesis","volume":"12","author":"Emori","year":"2014","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.canlet.2020.02.017_bib23","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ygyno.2013.12.015","article-title":"Exposure of fallopian tube epithelium to follicular fluid mimics carcinogenic changes in precursor lesions of serous papillary carcinoma","volume":"132","author":"Bahar-Shany","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2020.02.017_bib24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neo.2015.12.003","article-title":"Activation-induced cytidine deaminase links ovulation-induced inflammation and serous carcinogenesis","volume":"18","author":"Sapoznik","year":"2016","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2020.02.017_bib25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ygyno.2017.02.017","article-title":"Cytidine deaminase Apobec3a induction in fallopian epithelium after exposure to follicular fluid","volume":"145","author":"Brachova","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2020.02.017_bib26","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1530\/ERC-11-0107","article-title":"The impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancer","volume":"18","author":"King","year":"2011","journal-title":"Endocr. Relat. Canc."},{"key":"10.1016\/j.canlet.2020.02.017_bib27","doi-asserted-by":"crossref","first-page":"38983","DOI":"10.18632\/oncotarget.5493","article-title":"Role of miR-182 in response to oxidative stress in the cell fate of human fallopian tube epithelial cells","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2020.02.017_bib28","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1038\/onc.2015.425","article-title":"Transferrin facilitates the formation of DNA double-strand breaks via transferrin receptor 1: the possible involvement of transferrin in carcinogenesis of high-grade serous ovarian cancer","volume":"35","author":"Shigeta","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2020.02.017_bib29","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/path.4807","article-title":"Haemoglobin in pelvic fluid rescues Fallopian tube epithelial cells from reactive oxygen species stress and apoptosis","volume":"240","author":"Huang","year":"2016","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2020.02.017_bib30","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41389-019-0154-y","article-title":"Chronic iron exposure and c-Myc\/H-ras-mediated transformation in fallopian tube cells alter the expression of EVI1, amplified at 3q26.2 in ovarian cancer","volume":"8","author":"Rockfield","year":"2019","journal-title":"Oncogenesis"},{"key":"10.1016\/j.canlet.2020.02.017_bib31","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ebiom.2019.01.061","article-title":"IGF-axis confers transformation and regeneration of fallopian tube fimbria epithelium upon ovulation","volume":"41","author":"Hsu","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.canlet.2020.02.017_bib32","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3892\/or.2015.4048","article-title":"High IGF2 expression is associated with poor clinical outcome in human ovarian cancer","volume":"34","author":"Dong","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2020.02.017_bib33","doi-asserted-by":"crossref","first-page":"76881","DOI":"10.18632\/oncotarget.20173","article-title":"PAX2 maintains the differentiation of mouse oviductal epithelium and inhibits the transition to a stem cell-like state","volume":"8","author":"Alwosaibai","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2020.02.017_bib34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/CEJ.0000000000000217","article-title":"Ovarian cancer: epidemiology and risk factors","volume":"26","author":"La Vecchia","year":"2017","journal-title":"Eur. J. Canc. Prev."},{"key":"10.1016\/j.canlet.2020.02.017_bib35","series-title":"Intrauterine Contraception: Background and Device Types","author":"Madden","year":"2019"},{"key":"10.1016\/j.canlet.2020.02.017_bib36","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/AOG.0000000000003463","article-title":"Intrauterine device use and ovarian cancer risk: a systematic review and meta-analysis","volume":"134","author":"Wheeler","year":"2019","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.canlet.2020.02.017_bib37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0301-2115(97)02729-2","article-title":"The mammalian oviduct: biochemistry and physiology","volume":"73","author":"Menezo","year":"1997","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.canlet.2020.02.017_bib38","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jama.285.11.1460","article-title":"Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women","volume":"285","author":"Rodriguez","year":"2001","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.canlet.2020.02.017_bib39","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/jama.288.3.334","article-title":"Menopausal hormone replacement therapy and risk of ovarian cancer","volume":"288","author":"Lacey","year":"2002","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.canlet.2020.02.017_bib40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1477-7827-1-73","article-title":"Estrogen, progesterone and epithelial ovarian cancer","volume":"1","author":"Ho","year":"2003","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.canlet.2020.02.017_bib41","first-page":"40","article-title":"Is estradiol a genotoxic mutagenic carcinogen?","volume":"21","author":"Liehr","year":"2000","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.canlet.2020.02.017_bib42","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/oxfordjournals.jncimonographs.a024247","article-title":"Estrogens as endogenous genotoxic agents--DNA adducts and mutations","author":"Cavalieri","year":"2000","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"10.1016\/j.canlet.2020.02.017_bib43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13048-016-0213-3","article-title":"Genome-wide transcriptional regulation of estrogen receptor targets in fallopian tube cells and the role of selective estrogen receptor modulators","volume":"9","author":"Moyle-Heyrman","year":"2016","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.canlet.2020.02.017_bib44","article-title":"Reduced PAX2 expression in murine fallopian tube cells enhances estrogen receptor signaling","author":"Colina","year":"2019","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2020.02.017_bib45","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/14737140.2017.1272414","article-title":"Endocrine therapy in epithelial ovarian cancer","volume":"17","author":"Langdon","year":"2017","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.canlet.2020.02.017_bib46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/GCO.0000000000000423","article-title":"Endocrine therapy in ovarian cancer: where do we stand?","volume":"30","author":"Paleari","year":"2018","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.canlet.2020.02.017_bib47","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1634\/theoncologist.5-1-26","article-title":"Second-line treatment of ovarian cancer","volume":"5","author":"Markman","year":"2000","journal-title":"Oncol."},{"key":"10.1016\/j.canlet.2020.02.017_bib48","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1470-2045(13)70253-5","article-title":"Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study","volume":"14","author":"Sieh","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2020.02.017_bib49","doi-asserted-by":"crossref","first-page":"36845","DOI":"10.18632\/oncotarget.15982","article-title":"Prognostic value of progesterone receptor expression in ovarian cancer: a meta-analysis","volume":"8","author":"Luo","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2020.02.017_bib50","first-page":"2197","article-title":"Oral contraceptive use and impact of cumulative intake of estrogen and progestin on risk of ovarian cancer","volume":"24","author":"Faber","year":"2013","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.canlet.2020.02.017_bib51","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0140-6736(07)60534-0","article-title":"Ovarian cancer and hormone replacement therapy in the Million Women Study","volume":"369","author":"Beral","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2020.02.017_bib52","first-page":"708","article-title":"A quantitative assessment of oral contraceptive use and risk of ovarian cancer","volume":"80","author":"Hankinson","year":"1992","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.canlet.2020.02.017_bib53","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(94)90749-8","article-title":"Parity, age at first childbirth, and risk of ovarian cancer","volume":"344","author":"Adami","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2020.02.017_bib54","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1096\/fj.14-257352","article-title":"MUC16: molecular analysis and its functional implications in benign and malignant conditions","volume":"28","author":"Haridas","year":"2014","journal-title":"Faseb. J."},{"key":"10.1016\/j.canlet.2020.02.017_bib55","doi-asserted-by":"crossref","first-page":"13687","DOI":"10.3390\/ijms140713687","article-title":"Gene expression analyses support fallopian tube epithelium as the cell of origin of epithelial ovarian cancer","volume":"14","author":"O'Shannessy","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2020.02.017_bib56","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.rcl.2017.06.010","article-title":"Imaging and screening of ovarian cancer","volume":"55","author":"Lowry","year":"2017","journal-title":"Radiol. Clin."},{"key":"10.1016\/j.canlet.2020.02.017_bib57","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1476-4598-9-11","article-title":"MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells","volume":"9","author":"Gubbels","year":"2010","journal-title":"Mol. Canc."},{"key":"10.1016\/j.canlet.2020.02.017_bib58","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ygyno.2018.12.023","article-title":"MUC16 suppresses human and murine innate immune responses","volume":"152","author":"Felder","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2020.02.017_bib59","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ygyno.2011.02.020","article-title":"MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis","volume":"121","author":"Theriault","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2020.02.017_bib60","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ygyno.2009.08.007","article-title":"CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis","volume":"115","author":"Boivin","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2020.02.017_bib61","first-page":"280","article-title":"HN125: a novel immunoadhesin targeting MUC16 with potential for cancer therapy","volume":"2","author":"Xiang","year":"2011","journal-title":"J. Canc."},{"key":"10.1016\/j.canlet.2020.02.017_bib62","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ygyno.2004.04.024","article-title":"CA125- and tumor-specific T-cell responses correlate with prolonged survival in oregovomab-treated recurrent ovarian cancer patients","volume":"94","author":"Gordon","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2020.02.017_bib63","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1093\/annonc\/mdw401","article-title":"Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody-drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancer","volume":"27","author":"Liu","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2020.02.017_bib64","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1152\/physrev.2000.80.4.1523","article-title":"Prolactin: structure, function, and regulation of secretion","volume":"80","author":"Freeman","year":"2000","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.canlet.2020.02.017_bib65","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0015-0282(97)00320-8","article-title":"Prolactin gene expression and prolactin protein in premenopausal and postmenopausal human ovaries","volume":"68","author":"Schwarzler","year":"1997","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.canlet.2020.02.017_bib66","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.canlet.2018.07.003","article-title":"Prolactin signaling drives tumorigenesis in human high grade serous ovarian cancer cells and in a spontaneous fallopian tube derived model","volume":"433","author":"Karthikeyan","year":"2018","journal-title":"Canc. Lett."},{"key":"10.1016\/j.canlet.2020.02.017_bib67","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1158\/0008-5472.CAN-08-4652","article-title":"Biological significance of prolactin in gynecologic cancers","volume":"69","author":"Levina","year":"2009","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.02.017_bib68","first-page":"741","article-title":"Circulating prolactin levels and risk of epithelial ovarian cancer","volume":"24","author":"Clendenen","year":"2013","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.canlet.2020.02.017_bib69","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1158\/0008-5472.CAN-16-1454","article-title":"Prolactin receptor-mediated internalization of imaging agents detects epithelial ovarian cancer with enhanced sensitivity and specificity","volume":"77","author":"Sundaram","year":"2017","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.02.017_bib70","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fonc.2015.00154","article-title":"Spontaneous transformation of murine oviductal epithelial cells: a model system to investigate the onset of fallopian-derived tumors","volume":"5","author":"Endsley","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2020.02.017_bib71","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.canlet.2011.06.014","article-title":"Prolactin increases survival and migration of ovarian cancer cells: importance of prolactin receptor type and therapeutic potential of S179D and G129R receptor antagonists","volume":"310","author":"Tan","year":"2011","journal-title":"Canc. Lett."},{"key":"10.1016\/j.canlet.2020.02.017_bib72","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.celrep.2014.03.009","article-title":"Antagonism of tumoral prolactin receptor promotes autophagy-related cell death","volume":"7","author":"Wen","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2020.02.017_bib73","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/modpathol.2011.3","article-title":"PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study","volume":"24","author":"Ozcan","year":"2011","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.canlet.2020.02.017_bib74","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/1471-2407-14-292","article-title":"A role for PAX8 in the tumorigenic phenotype of ovarian cancer cells","volume":"14","author":"Di Palma","year":"2014","journal-title":"BMC Canc."},{"key":"10.1016\/j.canlet.2020.02.017_bib75","doi-asserted-by":"crossref","first-page":"12372","DOI":"10.1073\/pnas.1109363108","article-title":"Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer","volume":"108","author":"Cheung","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2020.02.017_bib76","doi-asserted-by":"crossref","first-page":"32785","DOI":"10.18632\/oncotarget.9051","article-title":"Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium","volume":"7","author":"Rodgers","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2020.02.017_bib77","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.1038\/s41388-019-0842-2","article-title":"Proteomic analysis reveals a role for PAX8 in peritoneal colonization of high grade serous ovarian cancer that can be targeted with micelle encapsulated thiostrepton","volume":"38","author":"Hardy","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2020.02.017_bib78","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.44306","article-title":"PAX8 regulon in human ovarian cancer links lineage dependency with epigenetic vulnerability to HDAC inhibitors","volume":"8","author":"Shi","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.canlet.2020.02.017_bib79","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.trsl.2016.03.016","article-title":"New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination","volume":"175","author":"Coffman","year":"2016","journal-title":"Transl. Res."},{"key":"10.1016\/j.canlet.2020.02.017_bib80","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1038\/srep06116","article-title":"Ovulation and extra-ovarian origin of ovarian cancer","volume":"4","author":"Yang-Hartwich","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2020.02.017_bib81","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/carcin\/bgy170","article-title":"Exposure of the extracellular matrix and colonization of the ovary in metastasis of fallopian-tube-derived cancer","volume":"40","author":"Dean","year":"2019","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2020.02.017_bib82","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models","volume":"24","author":"Perets","year":"2013","journal-title":"Canc. Cell"},{"key":"10.1016\/j.canlet.2020.02.017_bib83","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1089\/gtmb.2018.0157","article-title":"Relationship of WNT4 gene with the risk of epithelial ovarian cancer: a han Chinese population-based association study","volume":"22","author":"Zhang","year":"2018","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"10.1016\/j.canlet.2020.02.017_bib84","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.3185","article-title":"Identification of six new susceptibility loci for invasive epithelial ovarian cancer","volume":"47","author":"Kuchenbaecker","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2020.02.017_bib85","doi-asserted-by":"crossref","first-page":"20500","DOI":"10.18632\/oncotarget.3985","article-title":"Tumorigenesis and peritoneal colonization from fallopian tube epithelium","volume":"6","author":"Eddie","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2020.02.017_bib86","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1038\/s41388-017-0097-8","article-title":"PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation","volume":"37","author":"Russo","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2020.02.017_bib87","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1023\/B:HIJO.0000032355.66152.b8","article-title":"CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion","volume":"35","author":"Kucia","year":"2004","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.canlet.2020.02.017_bib88","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/bjc.2012.49","article-title":"The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer","volume":"106","author":"Popple","year":"2012","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.canlet.2020.02.017_bib89","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2006.02.036","article-title":"Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression","volume":"103","author":"Jiang","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2020.02.017_bib90","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1158\/1541-7786.MCR-09-0463","article-title":"Microenvironmental regulation of chemokine (C-X-C-motif) receptor 4 in ovarian carcinoma","volume":"8","author":"Barbolina","year":"2010","journal-title":"Mol. Canc. Res."},{"key":"10.1016\/j.canlet.2020.02.017_bib91","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1002\/jcp.27163","article-title":"Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro","volume":"234","author":"Liu","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.canlet.2020.02.017_bib92","doi-asserted-by":"crossref","first-page":"59123","DOI":"10.18632\/oncotarget.19289","article-title":"Mifepristone inhibits ovarian cancer metastasis by intervening in SDF-1\/CXCR4 chemokine axis","volume":"8","author":"Zheng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2020.02.017_bib93","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.canlet.2017.01.011","article-title":"Activin A stimulates migration of the fallopian tube epithelium, an origin of high-grade serous ovarian cancer, through non-canonical signaling","volume":"391","author":"Dean","year":"2017","journal-title":"Canc. Lett."},{"key":"10.1016\/j.canlet.2020.02.017_bib94","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1158\/1078-0432.CCR-19-1065","article-title":"First-in-Human phase I study of the activin A inhibitor, STM 434, in patients with granulosa cell ovarian cancer and other advanced solid tumors","volume":"25","author":"Tao","year":"2019","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2020.02.017_bib95","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1021\/acscentsci.8b00405","article-title":"Imaging mass spectrometry reveals crosstalk between the fallopian tube and the ovary that drives primary metastasis of ovarian cancer","volume":"4","author":"Zink","year":"2018","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.canlet.2020.02.017_bib96","doi-asserted-by":"crossref","first-page":"8291","DOI":"10.1038\/s41598-018-26670-4","article-title":"Early transcriptional response of human ovarian and fallopian tube surface epithelial cells to norepinephrine","volume":"8","author":"Gjyshi","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2020.02.017_bib97","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1517\/13543784.2010.515585","article-title":"Overcoming platinum resistance in ovarian carcinoma","volume":"19","author":"Matsuo","year":"2010","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.canlet.2020.02.017_bib98","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1158\/1078-0432.CCR-15-1275","article-title":"Adrenergic stimulation of DUSP1 impairs chemotherapy response in ovarian cancer","volume":"22","author":"Kang","year":"2016","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2020.02.017_bib99","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ygyno.2012.07.102","article-title":"Impact of beta blockers on epithelial ovarian cancer survival","volume":"127","author":"Diaz","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2020.02.017_bib100","unstructured":"Propranolol Hydrochloride and Chemotherapy in Treating Patients with Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, M.D. Anderson Cancer Center."},{"key":"10.1016\/j.canlet.2020.02.017_bib101","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Canc. Discov."},{"key":"10.1016\/j.canlet.2020.02.017_bib102","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.canlet.2020.02.017_bib103","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/ijc.29528","article-title":"Mutant p53 expression in fallopian tube epithelium drives cell migration","volume":"137","author":"Quartuccio","year":"2015","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.canlet.2020.02.017_bib104","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/j.celrep.2017.02.049","article-title":"Progesterone prevents high-grade serous ovarian cancer by inducing necroptosis of p53-defective fallopian tube epithelial cells","volume":"18","author":"Wu","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2020.02.017_bib105","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1158\/0008-5472.CAN-13-2247","article-title":"Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers","volume":"74","author":"Karst","year":"2014","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.02.017_bib106","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/cancers7010070","article-title":"Intertwining of activin A and TGFbeta signaling: dual roles in cancer progression and cancer cell invasion","volume":"7","author":"Loomans","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2020.02.017_bib107","doi-asserted-by":"crossref","first-page":"djt369","DOI":"10.1093\/jnci\/djt369","article-title":"TGF-beta: duality of function between tumor prevention and carcinogenesis","volume":"106","author":"Principe","year":"2014","journal-title":"J. Natl. Canc. Inst."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352030080X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352030080X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:48:07Z","timestamp":1759592887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438352030080X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":107,"alternative-id":["S030438352030080X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2020.02.017","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fallopian tube initiation of high grade serous ovarian cancer and ovarian metastasis: Mechanisms and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2020.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}